Clinical pharmacokinetic considerations in the elderly. An update

Area of Science:

• Geriatric Pharmacology
• Clinical Pharmacy
• Drug Safety in the Elderly

Background:

• Elderly populations exhibit complex drug handling, making in vitro or single-dose results difficult to interpret at steady-state.
• High incidence of adverse drug reactions in older adults necessitates improved pharmacotherapeutic strategies.
• Distinguishing age-related pharmacokinetic changes from those due to multiple pathologies is a significant challenge.

Purpose of the Study:

• To highlight the importance of understanding drug pharmacokinetics in the elderly.
• To address the challenges in assessing drug efficacy and safety in older individuals.
• To provide guidance on optimizing drug dosage regimens for elderly patients.

Main Methods:

• Review of existing studies on drug handling and pharmacokinetics in the elderly.
• Emphasis on individual patient assessment over generalized mean data.
• Discussion of strategies for dosage individualization and formulation selection.

Main Results:

• Standard doses for younger adults are often unsafe in the elderly; typically, one-third to half the dose is recommended.
• Plasma concentration monitoring and anticipating drug interactions are vital for minimizing toxicity.
• Adjusting dose frequency, rather than just dose size, may improve patient compliance.

Conclusions:

• Individualized dosage regimens are essential for safe and effective drug therapy in the elderly.
• Pharmacokinetic knowledge guides the selection of appropriate dosing strategies, including sustained-release formulations.
• Careful dose adjustment and vigilant monitoring are key to managing drug treatment in older patients.